Journal
JOURNAL OF CLINICAL MEDICINE
Volume 11, Issue 9, Pages -Publisher
MDPI
DOI: 10.3390/jcm11092380
Keywords
chronic kidney disease; percutaneous coronary intervention; contrast-induced nephropathy
Categories
Ask authors/readers for more resources
The net benefit of percutaneous coronary intervention (PCI) in patients with chronic kidney disease (CKD) is not well established. However, proper management is crucial to improve outcomes for this patient population, including pre-procedural preparation, reducing contrast usage during the procedure, implementing modern strategies, and personalized antithrombotic therapy.
Percutaneous coronary intervention (PCI) is one of the most common procedures performed in medicine. However, its net benefit among patients with chronic kidney disease (CKD) is less well established than in the general population. The prevalence of patients suffering from both CAD and CKD is high, and is likely to increase in the coming years. Planning the adequate management of this group of patients is crucial to improve their outcome after PCI. This starts with proper preparation before the procedure, the use of all available means to reduce contrast during the procedure, and the implementation of modern strategies such as radial access and drug-eluting stents. At the end of the procedure, personalized antithrombotic therapy for the patient's specific characteristics is advisable to account for the elevated ischemic and bleeding risk of these patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available